TrialBritish journal of cancer2023

Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.

Xue Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.